| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.19 | 0.0001 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0006 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.4 | 0.001 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |